Switch theme
Sign up to access all valuation multiples
Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold the number-one or -two positions in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating around 35% of sales from emerging markets.
2007
35.1K+
LTM Revenue $18.3B
LTM EBITDA $5.2B
$52.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Reckitt has a last 12-month revenue of $18.3B and a last 12-month EBITDA of $5.2B.
In the most recent fiscal year, Reckitt achieved revenue of $18.2B and an EBITDA of $3.8B.
Reckitt expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Reckitt valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $18.8B | $18.2B | XXX | XXX | XXX |
| Gross Profit | $10.8B | $11.3B | XXX | XXX | XXX |
| Gross Margin | 57% | 62% | XXX | XXX | XXX |
| EBITDA | $4.1B | $3.8B | XXX | XXX | XXX |
| EBITDA Margin | 22% | 21% | XXX | XXX | XXX |
| Net Profit | $3.0B | $2.1B | XXX | XXX | XXX |
| Net Margin | 16% | 12% | XXX | XXX | XXX |
| Net Debt | $9.8B | $9.1B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Reckitt's stock price is GBP 48 (or $61).
Reckitt has current market cap of GBP 32.5B (or $41.9B), and EV of GBP 40.4B (or $52.0B).
See Reckitt trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $52.0B | $41.9B | XXX | XXX | XXX | XXX | $4.49 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Reckitt has market cap of $41.9B and EV of $52.0B.
Reckitt's trades at 2.8x LTM EV/Revenue multiple, and 10.0x LTM EBITDA.
Analysts estimate Reckitt's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Reckitt and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $52.0B | XXX | XXX | XXX |
| EV/Revenue | 2.9x | XXX | XXX | XXX |
| EV/EBITDA | 13.7x | XXX | XXX | XXX |
| P/E | 22.8x | XXX | XXX | XXX |
| P/E/Growth | 0.7x | XXX | XXX | XXX |
| EV/FCF | 18.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpReckitt's NTM/LTM revenue growth is 2%
Reckitt's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Reckitt's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Reckitt's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Reckitt and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -3% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -7% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 23% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.5M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 25% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 9% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 36% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Reckitt acquired XXX companies to date.
Last acquisition by Reckitt was XXXXXXXX, XXXXX XXXXX XXXXXX . Reckitt acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Reckitt founded? | Reckitt was founded in 2007. |
| Where is Reckitt headquartered? | Reckitt is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Reckitt have? | As of today, Reckitt has 35.1K+ employees. |
| Who is the CEO of Reckitt? | Reckitt's CEO is Mr. Kris Licht. |
| Is Reckitt publicy listed? | Yes, Reckitt is a public company listed on LON. |
| What is the stock symbol of Reckitt? | Reckitt trades under RKT ticker. |
| When did Reckitt go public? | Reckitt went public in 2007. |
| Who are competitors of Reckitt? | Similar companies to Reckitt include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Reckitt? | Reckitt's current market cap is $41.9B |
| What is the current revenue of Reckitt? | Reckitt's last 12-month revenue is $18.3B. |
| What is the current EBITDA of Reckitt? | Reckitt's last 12-month EBITDA is $5.2B. |
| What is the current EV/Revenue multiple of Reckitt? | Current revenue multiple of Reckitt is 2.8x. |
| What is the current EV/EBITDA multiple of Reckitt? | Current EBITDA multiple of Reckitt is 10.0x. |
| What is the current revenue growth of Reckitt? | Reckitt revenue growth between 2023 and 2024 was -3%. |
| Is Reckitt profitable? | Yes, Reckitt is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
